Hypomania and mania related to dopamine replacement therapy in Parkinson's disease

被引:28
|
作者
Maier, Franziska [1 ]
Merkl, Josuah [1 ]
Ellereit, Anna L. [1 ]
Lewis, Catharine J. [1 ]
Eggers, Carsten [1 ]
Pedrosa, David J. [1 ]
Kalbe, Elke [1 ,2 ]
Kuhn, Jens [3 ]
Meyer, Thomas D. [4 ]
Zurowski, Mateusz [5 ]
Timmermann, Lars [1 ]
机构
[1] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany
[2] Univ Vechta, Inst Gerontol, Vechta, Germany
[3] Univ Cologne, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany
[4] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[5] Univ Toronto, Dept Psychiat, Univ Hlth Network, Toronto, ON, Canada
关键词
Parkinson's disease; Dopamine replacement therapy; Hypomania; Mania; Dopamine dysregulation; Impulse control disorders; DEEP BRAIN-STIMULATION; IMPULSE CONTROL; DISORDERS; PREVALENCE;
D O I
10.1016/j.parkreldis.2014.01.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To investigate hypomania and mania related to dopamine replacement therapy (DRT) in Parkinson's disease (PD). Methods: We recruited 108 non-demented PD patients without deep brain stimulation from a movement disorders in and outpatient clinic. Forty-five age- and gender-matched controls were also included. Disease characteristics, cognitive functioning, comorbid psychiatric diseases, dopaminergic and psychiatric medication were evaluated. Diagnosis of DRT-related hypomania and mania was based on DSM-IV-TR criteria with supplementary assessment of two mania self-rating scales. First, patients and controls were compared. Patients with DRT-related hypomania or mania were then compared to the remaining patients. A binary logistic regression analysis was performed to identify correlates of DRT-related hypomania. Results: Patients scored significantly higher on mania self-rating scales than controls. Twelve patients (11.1%) had DRT-related hypomania and six patients (5.6%) had DRT-related mania. Both groups had significantly higher self-rating mania-scores than patients without these mood states. DRT-related hypomania was significantly related to younger age, younger age at PD onset, dyskinesias, higher levodopa equivalent daily dose, dopamine dysregulation, and amantadine treatment. In contrast, DRT-related mania was significantly associated with hallucinations and delusions, history of levodopa-induced psychosis, quetiapine treatment, higher depression and daily levodopa dose, and cognitive deficits. Regression analysis revealed dopamine dysregulation, dyskinesias, amantadine treatment, and younger age at PD onset as significant correlates of DRT-related hypomania. Conclusion: DRT-related hypomania and mania are relevant comorbidities in PD. DRT-related hypomania may exist as a distinct psychiatric symptom complex in young patients with early disease onset. Different patient profiles likely underlie DRT-related hypomania and mania. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:421 / 427
页数:7
相关论文
共 50 条
  • [31] Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson's Disease
    Luthra, Pratibha Mehta
    Kumar, J. B. Senthil
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (14) : 1556 - 1564
  • [32] The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease
    Ahlskog, JE
    Uitti, RJ
    O'Connor, MK
    Maraganore, DM
    Matsumoto, JY
    Stark, KF
    Turk, MF
    Burnett, OL
    MOVEMENT DISORDERS, 1999, 14 (06) : 940 - 946
  • [33] Pathological gambling in Parkinson's disease: disease related or drug related?
    Calandrella, Daniela
    Antonini, Angelo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (06) : 809 - 814
  • [34] Impulsive and Compulsive Behaviors During Dopamine Replacement Treatment in Parkinson's Disease and Other Disorders
    Raja, Michele
    Bentivoglio, Anna Rita
    CURRENT DRUG SAFETY, 2012, 7 (01) : 63 - 75
  • [35] Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner
    Cherkasova, Mariya V.
    Corrow, Jeffrey C.
    Taylor, Alisdair
    Yeung, Shanna C.
    Stubbs, Jacob L.
    McKeown, Martin J.
    Appel-Cresswell, Silke
    Stoessl, A. Jon
    Barton, Jason J. S.
    PARKINSONISM & RELATED DISORDERS, 2019, 66 : 189 - 194
  • [36] Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease
    Fenu, Sandro
    Wardas, Jadwiga
    Morelli, Micaela
    BEHAVIOURAL PHARMACOLOGY, 2009, 20 (5-6): : 363 - 379
  • [37] Rational therapy of idiopathic Parkinson's disease with dopamine agonists
    Reichnnann, H.
    AKTUELLE NEUROLOGIE, 2007, 34 : S265 - S269
  • [38] Mania Following Subthalamic Nucleus Stimulation for Parkinson's Disease
    Velosa, Ana
    Silva, Bruno
    Oliveira-Maia, Albino J.
    Bugalho, Paulo
    Barahona-Correa, Bernardo
    PSILOGOS, 2019, 17 (1-2) : 132 - 138
  • [39] Dopamine receptor agonists for Parkinson's disease
    Blandini, Fabio
    Armentero, Marie-Therese
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (03) : 387 - 410
  • [40] A Pilot Trial of Dopamine Replacement for Dynamic Facial Expressions in Parkinson's Disease
    Schade, Rachel N.
    Springer, Utaka
    Mikos, Ania
    Gokcay, Didem
    Clark, Alexandra
    Sapienza, Christine
    Fernandez, Hubert H.
    Okun, Michael S.
    Bowers, Dawn
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (02): : 213 - 222